CORPORATE RESPONSIBILITY REPORT
For more than a century, our company has been inventing medicines and vaccines for the world’s most challenging diseases. Our 2017/2018 Corporate Responsibility Report illustrates our ongoing quest to save and improve lives through invention while also contributing to a healthier and more hopeful world.READ THE REPORT
Addressing 88 percent of the top 20 global burdens of disease with our products and pipeline.
Launching new initiatives to improve the health of underserved communities with chronic diseases and saving the lives of more women through MSD for Mothers, our global initiative to end preventable maternal deaths
Advancing progress towards our 2025 goal of having more than 50 percent of our purchased electricity come from renewable sources
Increasing our business with diverse suppliers by an additional 31% over 2016's 57% increase, exceeding our corporate goal of achieving $1.2 billion in spend in 2017.
Expanding the reach of our Animal Health business through new products and educational initiatives
Building an environment where diversity and inclusion is woven into the fabric of our culture
Our R&D efforts prioritize promising research and clinical development that represent breakthrough science and target many of the world's most urgent global health challenges.